Highlights in Multiple Myeloma

From the 2025 American Society of Hematology Annual Meeting December 6-9, 2025 • Orlando, Florida Teclistamab/Daratumumab Combination Improves Survival in Relapsed/Refractory Myeloma Progression-free survival (PFS) and […]

Highlights in Upper Gastrointestinal Cancer

From the 2025 American Society of Clinical Oncology Annual Meeting May 30-June 3, 2025 • Chicago, Illinois Addition of Durvalumab to Chemotherapy Improves Event-Free Survival in […]

Highlights in Prostate Cancer From the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium

January 25-27, 2024 • San Francisco, California and Virtual Abiraterone Plus Olaparib Improves Outcomes in Metastatic Castration-Resistant Prostate Cancer A combination of abiraterone and olaparib (Lynparza, […]

Highlights in Prostate Cancer From the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium

February 16-18, 2023 • San Francisco, California and Virtual Talazoparib Improves Radiographic Progression-Free Survival in Patients With Metastatic Castration-Resistant Prostate Cancer The addition of talazoparib (Talzenna, […]

Highlights From the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium

January 17-19, 2022 • San Francisco, California, and Online Addition of Olaparib to Abiraterone Improves Progression-Free Survival in First-Line Metastatic Castration-Resistant Prostate Cancer The addition of […]

Highlights in Breast Cancer From the 2016 American Society of Clinical Oncology Annual Meeting, June 3-7, 2016, Chicago, Illinois

Clinical Advances in Hematology & Oncology Volume 14, Issue 7, July 2016 Commentary by Hope S. Rugo, MD Abemaciclib Shows Signs of Efficacy and Tolerability in […]

Highlights From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium

Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 January 7-9, 2016 • San Francisco, California Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer […]

Highlights in Kidney Cancer From the 2015 American Society of Clinical Oncology Annual Meeting

Highlights in Kidney Cancer From the 2015 American Society of Clinical Oncology Annual Meeting May 29-June 2, 2015 • Chicago, Illinois Biomarkers Associated With Improved Clinical […]

Highlights in Breast Cancer From the 2015 American Society of Clinical Oncology Annual Meeting

Clinical Advances in Hematology & Oncology July 2015, Volume 13, Issue 7 Commentary by Edith A. Perez, MD Response Rates High for T-DM1 in HER2-Positive/HR-Positive Early […]

Highlights in Disorders of Coagulation and Thrombosis From the 2014 American Society of Hematology Meeting

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2 December 6-9, 2014 • San Francisco, California Devon Schuyler and Kathryn Turner, PhD […]

Highlights From the 2014 Congress of the European Hematology Association

Clinical Advances in Hematology & Oncology September 2014, Volume 12, Issue 9 June 12-15, 2014 • Milan, Italy Commentary by Bruce D. Cheson, MD NHL […]

Highlights in Breast Cancer from the 2014 American Society of Clinical Oncology Annual Meeting

July 2014, Volume 12, Issue 7 Highlights in Breast Cancer from the 2014 American Society of Clinical Oncology Annual Meeting May 30-June 3, 2014 Chicago, Illinois […]

Highlights in Hemophilia and von Willebrand Disease From the 2013 American Society of Hematology Meeting

Clinical Advances in Hematology & Oncology February 2014, Volume 12, Issue 2 Highlights in Hemophilia and von Willebrand Disease From the 2013 American Society of Hematology […]